NCT01317134 Endothelial Function in Patients With Pulmonary Arterial Hypertension Status COMPLETED Phase NA
NCT01302444 Treprostinil Combined With Tadalafil for Pulmonary Hypertension Status TERMINATED Phase PHASE4
NCT01268553 Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication Status COMPLETED Phase PHASE4
NCT01266265 Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies Status COMPLETED Phase N/A
NCT01265888 Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Status COMPLETED Phase PHASE2
NCT01260454 The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain Status COMPLETED Phase PHASE2
NCT01244620 A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses Status TERMINATED Phase PHASE1
NCT01223352 Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE3
NCT01181284 Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA) Status COMPLETED Phase N/A
NCT01179737 Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH) Status TERMINATED Phase PHASE2
NCT01172496 A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01165476 Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities Status COMPLETED Phase PHASE1
NCT01153386 Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine Status COMPLETED Phase PHASE1
NCT01131845 The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil Status COMPLETED Phase PHASE1